Abstract
One of the most promising areas of research into the biological underpinnings of depression is genetic studies. However, the absence of generally accepted phenotyping methods leads to the difficulties in generalizing their results due to the heterogeneity of the samples. Thus, the development of a reliable and convenient phenotyping method that allows large sample sizes to be included in studies remains a top priority for the further development of genetic studies of depression.
The aim of this study was to evaluate the applicability of the online version of the depression subscale of Hospital Anxiety and Depression Scale (HADS-D) for depression phenotype screening in the general population. Using online HADS-D we performed screening of depressive symptoms and compared results with known population patterns of depression.
We conducted an online survey of 2610 Russian-speaking respondents over the age of 18. The overall HADS-D score was higher in women (p=0.003), in individuals under 30 y.o compared to participants over 42 y.o. (p=0.004) and in individuals reporting cardiovascular diseases (CVD) symptoms (p<0.0001).
Linear regression showed that the presence of CVD leads to higher HADS-D scores (p<0.001), male gender (p=0.002) and older age (p<0.001) led to lower scores. Logistic regression showed that CVD increases the risk of having depression symptoms by HADS-D (p=0.033, OR=1.29), older age (p=0.015, OR=0.87) and male sex (as a trend, p=0.052, OR=0.80) decrease this risk.
These results are consistent with the known data on the association of sex, age, and the presence of CVD with the prevalence of depression. The online version of HADS-D, given the ease of its usage, can be regarded as an effective tool for phenotyping depression in the general population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by Russian Science Foundation Grant №20-15-00132
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All research was approved by the ethics committee of Genotek Ltd.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: This research was supported by Russian Science Foundation Grant №20-15-00132
About the authors: Kibitov AA (Андрей Александрович Кибитов) – clinical resident of Translational Psychiatry Department, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Rakitko AS (Александр Сергеевич Ракитько) – head of statistics department, Genotek Ltd, associate researcher of Translational Psychiatry Department, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Kasyanov ED (Евгений Дмитриевич Касьянов)– PhD student of Translational Psychiatry Department, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Rukavishnikov GV (Григорий Викторович Рукавишников) – lead researcher of Translational Psychiatry Department, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Kozlova KA (Кира Александровна Козлова) – student of Faculty of Mechanics and Mathematics, Lomonosov Moscow State University
Ilinsky VV (Валерий Владимирович Ильинский) – CEO of Genotek Ltd., associate researcher of Translational Psychiatry Department, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Neznanov GN (Николай Григорьевич Незнанов) – head of V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, head of Psychiatry and Nacrology Department, First Pavlov State Medical University of St. Petersburg.
Mazo GE (Галина Элевна Мазо) – head of Translational Psychiatry Department, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Kibitov AO (Александр Олегович Кибитов) – head of Laboratory of Molecular Genetics, Serbsky National Medical Research Center on Psychiatry and Addictions, associate researcher of Translational Psychiatry Department, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Data Availability
STROBE (EQUATOR Network) check-list for this study: https://dfiles.eu/files/jqd7cqtro?redirect
